These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34359622)

  • 1. Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach.
    Daun T; Nienhold R; Paasinen-Sohns A; Frank A; Sachs M; Zlobec I; Cathomas G
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.
    Ramos MFKP; Pereira MA; de Mello ES; Cirqueira CDS; Zilberstein B; Alves VAF; Ribeiro-Junior U; Cecconello I
    World J Clin Oncol; 2021 Aug; 12(8):688-701. PubMed ID: 34513602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
    Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM
    Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications.
    Koh J; Lee KW; Nam SK; Seo AN; Kim JW; Kim JW; Park DJ; Kim HH; Kim WH; Lee HS
    Oncologist; 2019 Dec; 24(12):e1321-e1330. PubMed ID: 31371521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases.
    Bösch F; Todorova R; Link H; Westphalen CB; Boeck S; Heinemann V; Werner J; Kirchner T; Angele MK; Neumann J
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2689-2697. PubMed ID: 31541339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
    Di Pinto F; Armentano R; Arborea G; Schena N; Donghia R; Valentini AM
    Oncology; 2020; 98(8):566-574. PubMed ID: 32316005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles of gastric cancer molecular subtypes in remnant tumors.
    Ramos MFKP; Pereira MA; Cardili L; de Mello ES; Ribeiro U; Zilberstein B; Cecconello I
    World J Gastrointest Oncol; 2021 Apr; 13(4):265-278. PubMed ID: 33889278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
    Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
    Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
    Gonzalez RS; Messing S; Tu X; McMahon LA; Whitney-Miller CL
    Hum Pathol; 2016 Oct; 56():16-21. PubMed ID: 27342907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
    Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
    Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability.
    Pinto MP; Córdova-Delgado M; Retamal IN; Muñoz-Medel M; Bravo ML; Durán D; Villanueva F; Sanchez C; Acevedo F; Mondaca S; Koch É; Ibañez C; Galindo H; Madrid J; Nervi B; Peña J; Torres J; Owen GI; Corvalán AH; Armisén R; Garrido M
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric Cancer Genomics: Advances and Future Directions.
    Katona BW; Rustgi AK
    Cell Mol Gastroenterol Hepatol; 2017 Mar; 3(2):211-217. PubMed ID: 28275688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications.
    Ahn S; Lee SJ; Kim Y; Kim A; Shin N; Choi KU; Lee CH; Huh GY; Kim KM; Setia N; Lauwers GY; Park DY
    Am J Surg Pathol; 2017 Jan; 41(1):106-115. PubMed ID: 27819872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protein and mRNA expression-based classification of gastric cancer.
    Setia N; Agoston AT; Han HS; Mullen JT; Duda DG; Clark JW; Deshpande V; Mino-Kenudson M; Srivastava A; Lennerz JK; Hong TS; Kwak EL; Lauwers GY
    Mod Pathol; 2016 Jul; 29(7):772-84. PubMed ID: 27032689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing an integrated molecular classification for gastric cancer from endoscopic biopsies using on-slide tests.
    Costache S; Baltan A; Diaz McLynn S; Pegoraro M; de Havilland R; Porter M; Lerga A; Thomas T; Chefani AE; Wedden S; Billingham K; D'Arrigo C
    Rom J Morphol Embryol; 2024; 65(2):257-265. PubMed ID: 39020540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
    Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC
    Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].
    Liu Y; Zang FL; Qiu ZQ; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Liang H; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):440-448. PubMed ID: 34000774
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes.
    Angerilli V; Pennelli G; Galuppini F; Realdon S; Fantin A; Savarino E; Farinati F; Mastracci L; Luchini C; Fassan M
    Virchows Arch; 2022 Oct; 481(4):545-552. PubMed ID: 35925389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
    Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
    Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer.
    Sun Y; Yu W; Guan W; Cai L; Qiao M; Zheng L; Jiang R; Wang R; Wang L
    Cancer Manag Res; 2019; 11():6397-6410. PubMed ID: 31372044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.